A number of studies focus on survivin, an Hsp90 client IAP virtually undetectable in most normal tissues, but highly expressed in a range of human tumours, where its presence is often correlated with both accelerated relapse and chemotherapy resistance. Here, HSP90AA1 is linked to neoplasm.